Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
24.51 USD
2.51%
Market Closed
Updated:
Jun 11, 2024
Arrowhead Pharmaceuticals Inc
Common Shares Outstanding
|
Arrowhead Pharmaceuticals Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Common Shares Outstanding
$124.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Arrowhead Pharmaceuticals Inc's Common Shares Outstanding?
Common Shares Outstanding
124.1m
USD
124.1m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Common Shares Outstanding amounts to 124.1m USD.
What is Arrowhead Pharmaceuticals Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
9%
9%
Over the last year, the Common Shares Outstanding growth was 16%. The average annual Common Shares Outstanding growth rates for Arrowhead Pharmaceuticals Inc have been 6% over the past three years , 6% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
